Indian Study Shows Type 2 Diabetes Remission May Be Possible without Surgery or Extreme Diets
A new study published in the Indian Journal of Endocrinology and Metabolism is challenging long-held beliefs about type 2 diabetes mellitus (T2DM). The 'DiaRem-1' trial, conducted at a single center in India, shows that with a strategic combination of medication and lifestyle modifications, remission of T2DM may be possible.
The trial targeted adults diagnosed with T2DM within the past five years, with an HbA1c level below 8.5%. After an initial three-month period of medication, participants were taken off all antidiabetic drugs for another three months to assess for remission—defined in the study as maintaining an HbA1c level below 6.5% without any diabetes medication.
Participants were divided into two treatment arms. Fourteen patients in the intervention arm received a combination of liraglutide, dapagliflozin, and metformin. The control group of fifteen patients was treated with vildagliptin, glimepiride, and metformin. Both groups also received guidance on maintaining a home-based, healthy diet and daily physical activity, including brisk walking, yoga, or dancing.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.